NHS, endometriosis and Ryeqo

New endometriosis pill: How does endometriosis drug Ryeqo work, and is it available on the NHS in Scotland?
Ryeqo drug is hailed as a ‘potential step-change’ in how endometriosis is treated A new pill designed to transform the treatment of endometriosis has been approved for use on the NHS in England and Wales.
NHS approves long-term daily pill for endometriosis in England
The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), the first long-term pill available for endometriosis, marking a significant breakthrough in treatment.
Daily endometriosis pill Ryeqo to be made available on NHS in Wales
Ryeqo is likely to start being prescribed to patients in Wales within two months, but there will be restrictions on who can access it
'Transformational' pill for endometriosis gets NHS nod
Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap (leuprorelin acetate) and AstraZeneca's Zoladex (goserelin acetate) – which are only licensed for up to six months – can be taken up until menopause.
First daily pill for endometriosis approved for NHS use
The treatment, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), works by blocking specific hormones that contribute to endometriosis, while also providing necessary hormone replacement in a single daily tablet.
'First-of-a-kind' pill for endometriosis is approved by the NHS – but is it really a miracle drug?
Managing debilitating symptoms for a condition that has no cure or universal treatment is almost impossible – and it's the reality for the 1.5 million women and those born female with endometriosis in the UK.
NHS approve new pill that will 'transform' the treatment of endometriosis
The NHS has approved a new pill that is designed to transform the treatment of endometriosis. The combination drug will help around 1,000 women every year in England who suffer from the debilitating condition.
A New Pill Will Soon Be Available For Endometriosis Patients – Here’s What You Should Know
Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...
Stylist2d
A new treatment for endometriosis is finally available on the NHS – here’s what you need to know
The new tablet, known as Ryeqo or relugolix-estradiol-norethisterone, has been approved to treat women of reproductive age ...
pharmaphorum2d
Gedeon Richter gets NICE nod for uterine fibroids drug Ryeqo
Ryeqo was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) last October based on results from the LIBERTY programme, consisting of two 24-week phase 3 clinical trials.